Strides receives Health Canada approval for Ondansetron injection

New Delhi, Aug 8 (UNI) Pharma company Strides Arcolab Ltd today announced its first ANDS approval for Ondansetron Injection 2 mg / ml.

The product is licensed to an undisclosed partner in Canada and expects sales to commence in Q4 2007, said a company statement.

''We are delighted with our first Canadian approval for an important sterile product and are delighted having achieved a further milestone in creating a global sterile injectable business,'' company's Vice Chairman and Managing Director Arun Kumar said.

Ondansetron is a first amongst various sterile submissions the company has submitted with Health Canada.

UNI